Vita Life Sciences Limited (ASX:VLS)

Market Cap	136.55M
Revenue (ttm)	85.60M +9.1%
Net Income	9.31M -1.1%
EPS	0.17 -3.5%
Shares Out	54.62M
PE Ratio	15.10
Forward PE	n/a
Dividend	0.10 (3.75%)
Ex-Dividend Date	Sep 19, 2025

Volume	10,036
Average Volume	8,448
Open	2.430
Previous Close	2.500
Day's Range	2.270 - 2.470
52-Week Range	1.620 - 2.840
Beta	0.57
RSI	41.34
Earnings Date	Feb 24, 2026

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2024, Vita Life Sciences's revenue was 79.51 million, an increase of 8.28% compared to the previous year's 73.43 million. Earnings were 8.78 million, a decrease of -3.26%.